Implementing an i.v. iron maintenance regimen protocol in a hemodialysis practice.
Iron-deficiency anemia is commonly encountered in patients with end-stage renal disease (ESRD) requiring chronic hemodialysis and can occur as a result of blood loss from frequent laboratory tests, blood retention in the dialysis tubing and dialyzer, gastrointestinal (GI) bleeding, repeated access surgery, poor oral iron intake and/or absorption, and low protein diets (Sakiewicz, 1998; Eschbach, 1999). Further compounding the deficiency is the use of recombinant human erythropoietin (EPO), which stimulates erythropoiesis to abnormally high levels and leads to functional iron deficiency in up to 90% of patients (Macdougall, 1995; Sunder-Plassmann, 1997).
Gilmartin
Cheryl
C
University of Illinois at Chicago, Chicago, IL, USA.
Na-Thalang
Kwanta
K
Arruda
Jose
J
Lau
Alan
A
D000368:Aged; D018798:Anemia, Iron-Deficiency / Q000209:etiology / Q000517:prevention & control*; D002985:Clinical Protocols; D000075202:Contraindications; D005260:Female; D006284:Health Plan Implementation; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*
D007501:Iron